-
Small molecule drug development using proprietary technology to screen interactions with human proteins, in target-specific programs to present as clinical-stage compounds. Profile of company based in San Diego, California.
-
Develops and markets proteomics based tests for cancer. Descriptions of products, and background on the technology are included.
-
Provider of integrated solutions for protein research in expression markers, at Philadelphia and Alconbury. England.
-
Specializes in interpretation of 2-dimensional gels, and developing point-of-care diagnostics in the areas of cystic fibrosis, cancer, infectious disease and aging. Includes alpha-amylase test, and research programs, with contacts in USA, Japan and headquarters in Sydney, Australia.
|
|
